Altering routine practice patterns could alleviate more than half of hospital litigation costs related to obstetric malpractice.
Altering routine practice patterns could alleviate more than half of hospital litigation costs related to obstetric malpractice, according to a report published in the December issue of Obstetrics and Gynecology.
Steven L. Clark, MD, of the Hospital Corporation of America in Nashville, TN., and colleagues reviewed 189 perinatal legal claims, totaling $168 million, to examine how the cost of obstetric malpractice suits might be reduced. Each claim was evaluated using three criteria: whether substandard care caused the adverse outcome; what practice changes could have avoided that adverse outcome; and whether inadequate documentation caused payment to be made despite missing objective evidence. All of the claims were closed and had occurred between 2000 and 2005.
The researchers report that 70% of the obstetric-related claims were associated with substandard care, accounting for 79% of the total $168 million. Several adverse outcomes-including non-vaginal birth after cesarean, VBAC-related fetal monitoring, maternal injury, and shoulder dystocia-would have been avoidable with the implementation of four practice patterns, including delivery in a facility with constant obstetric coverage, improved adherence to protocols for high-risk medication, a more conservative approach to VBAC, and use of a comprehensive standardized procedure for cases of shoulder dystocia, the report indicates.
Daré Bioscience initiates phase 3 clinical trial for ovaprene contraceptive
December 5th 2023Daré Bioscience has commenced a pivotal phase 3 clinical trial for ovaprene, an intravaginal contraceptive that releases a locally acting agent to prevent sperm entry into the cervical canal, marking a significant step towards a non-hormonal contraceptive option for women.
Read More
Exploring menstrual health: Insights from the Avon longitudinal study
December 5th 2023Unveiling a comprehensive analysis of menstrual cycle characteristics in mothers and daughters, this article delves into the diverse features, potential risk factors, and the importance of understanding these nuances for effective menstrual health management.
Read More
Integrating pharmacists into PPHTN management for enhanced blood pressure control
December 4th 2023A study reveals that involving pharmacists in the care of postpartum women at risk of persistently elevated blood pressure, as presented at the American Society of Health-System Pharmacists 2023 Midyear Clinical Meeting and Exhibition, can provide an effective and feasible solution to managing hypertensive disorders, reducing postpartum readmission risks, and improving overall health care access.
Read More